|
1
|
Lewin GR and Barde YA: Physiology of the
neurotrophins. Annu Rev Neurosci. 19:289–317. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Novikov L, Novikova L and Kellerth JO:
Brain-derived neurotrophic factor promotes axonal regeneration and
long-term survival of adult rat spinal motoneurons in vivo.
Neuroscience. 79:765–774. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lattanzio F, Carboni L, Carretta D,
Candeletti S and Romualdi P: Treatment with the neurotoxic Aβ
(25–35) peptide modulates the expression of neuroprotective factors
Pin1, Sirtuin 1, and brain-derived neurotrophic factor in SH-SY5Y
human neuroblastoma cells. Exp Toxicol Pathol. 68:271–276. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guo D, Hou X, Zhang H, Sun W, Zhu L, Liang
J and Jiang X: More expressions of BDNF and TrkB in multiple
hepatocellular carcinoma and anti-BDNF or K252a induced apoptosis,
supressed invasion of HepG2 and HCCLM3 cells. J Exp Clin Cancer
Res. 30:972011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pearse RN, Swendeman SL, Li Y, Rafii D and
Hempstead BL: A neurotrophin axis in myeloma: TrkB and BDNF promote
tumor-cell survival. Blood. 105:4429–4436. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miknyoczki SJ, Wan W, Chang H, Dobrzanski
P, Ruggeri BA, Dionne CA and Buchkovich K: The neurotrophin-trk
receptor axes are critical for the growth and progression of human
prostatic carcinoma and pancreatic ductal adenocarcinoma xenografts
in nude mice. Clin Cancer Res. 8:1924–1931. 2002.PubMed/NCBI
|
|
7
|
Jia S, Wang W, Hu Z, Shan C, Wang L, Wu B,
Yang Z, Yang X and Lei D: BDNF mediated TrkB activation contributes
to the EMT progression and the poor prognosis in human salivary
adenoid cystic carcinoma. Oral Oncol. 51:64–70. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stephan H, Zakrzewski JL, Bölöni R,
Grasemann C, Lohmann DR and Eggert A: Neurotrophin receptor
expression in human primary retinoblastomas and retinoblastoma cell
lines. Pediatr Blood Cancer. 50:218–222. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Thiele CJ, Li Z and McKee AE: On
Trk - the TrkB signal transduction pathway is an
increasingly important target in cancer biology. Clin Cancer Res.
15:5962–5967. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ricci A, Graziano P, Mariotta S, Cardillo
G, Sposato B, Terzano C and Bronzetti E: Neurotrophin system
expression in human pulmonary carcinoid tumors. Growth Factors.
23:303–312. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rosean TR, Tompkins VS, Tricot G, Holman
CJ, Olivier AK, Zhan F and Janz S: Preclinical validation of
interleukin 6 as a therapeutic target in multiple myeloma. Immunol
Res. 59:188–202. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Z, Zhang Y, Tong Y, Tong J and Thiele
CJ: Trk inhibitor attenuates the BDNF/TrkB-induced protection of
neuroblastoma cells from etoposide in vitro and in vivo. Cancer
Biol Ther. 16:477–483. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kupferman ME, Jiffar T, El-Naggar A,
Yilmaz T, Zhou G, Xie T, Feng L, Wang J, Holsinger FC, Yu D, et al:
TrkB induces EMT and has a key role in invasion of head and neck
squamous cell carcinoma. Oncogene. 29:2047–2059. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Douma S, Van Laar T, Zevenhoven J,
Meuwissen R, Van Garderen E and Peeper DS: Suppression of anoikis
and induction of metastasis by the neurotrophic receptor TrkB.
Nature. 430:1034–1039. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun CY, Hu Y, Wang HF, He WJ, Wang YD and
Wu T: Brain-derived neurotrophic factor inducing angiogenesis
through modulation of matrix-degrading proteases. Chin Med J.
119:589–595. 2006.PubMed/NCBI
|
|
16
|
Sharp PA: RNA interference - 2001. Genes
Dev. 15:485–490. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hutvágner G and Zamore PD: RNAi: Nature
abhors a double-strand. Curr Opin Genet Dev. 12:225–232. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hannon GJ and Rossi JJ: Unlocking the
potential of the human genome with RNA interference. Nature.
431:371–378. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bernstein E, Caudy AA, Hammond SM and
Hannon GJ: Role for a bidentate ribonuclease in the initiation step
of RNA interference. Nature. 409:363–366. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hammond SM, Boettcher S, Caudy AA,
Kobayashi R and Hannon GJ: Argonaute2, a link between genetic and
biochemical analyses of RNAi. Science. 293:1146–1150. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mousavi K and Jasmin BJ: BDNF is expressed
in skeletal muscle satellite cells and inhibits myogenic
differentiation. J Neurosci. 26:5739–5749. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yan QS, Feng MJ and Yan SE: RNA
interference-mediated inhibition of brain-derived neurotrophic
factor expression increases cocaine's cytotoxicity in cultured
cells. Neurosci Lett. 414:165–169. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Reynolds A, Leake D, Boese Q, Scaringe S,
Marshall WS and Khvorova A: Rational siRNA design for RNA
interference. Nat Biotechnol. 22:326–330. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eaton MJ and Whittemore SR: Autocrine BDNF
secretion enhances the survival and serotonergic differentiation of
raphe neuronal precursor cells grafted into the adult rat CNS. Exp
Neurol. 140:105–114. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nakamura Y, Suganami A, Fukuda M, Hasan
MK, Yokochi T, Takatori A, Satoh S, Hoshino T, Tamura Y and
Nakagawara A: Identification of novel candidate compounds targeting
TrkB to induce apoptosis in neuroblastoma. Cancer Med. 3:25–35.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Streiter S, Fisch B, Sabbah B, Ao A and
Abir R: The importance of neuronal growth factors in the ovary. Mol
Hum Reprod. 22:3–17. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Clemons M and Goss P: Estrogen and the
risk of breast cancer. N Engl J Med. 344:276–285. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Burry K and Cain JM: Estrogen replacement
therapy and risk of ovarian cancer in postmenopausal women. JAMA.
288:2538author reply 2539. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen GG, Zeng Q and Tse GM: Estrogen and
its receptors in cancer. Med Res Rev. 28:954–974. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nair HB, Luthra R, Kirma N, Liu YG,
Flowers L, Evans D and Tekmal RR: Induction of aromatase expression
in cervical carcinomas: Effects of endogenous estrogen on cervical
cancer cell proliferation. Cancer Res. 65:11164–11173. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sohrabji F, Miranda RC and Toran-Allerand
CD: Identification of a putative estrogen response element in the
gene encoding brain-derived neurotrophic factor. Proc Natl Acad Sci
USA. 92:11110–11114. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Singh M, Meyer EM and Simpkins JW: The
effect of ovariectomy and estradiol replacement on brain-derived
neurotrophic factor messenger ribonucleic acid expression in
cortical and hippocampal brain regions of female Sprague-Dawley
rats. Endocrinology. 136:2320–2324. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Solum DT and Handa RJ: Estrogen regulates
the development of brain-derived neurotrophic factor mRNA and
protein in the rat hippocampus. J Neurosci. 22:2650–2659.
2002.PubMed/NCBI
|
|
34
|
Blurton-Jones M, Kuan PN and Tuszynski MH:
Anatomical evidence for transsynaptic influences of estrogen on
brain-derived neurotrophic factor expression. J Comp Neurol.
468:347–360. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hu Y, Sun CY, Wang HF, Guo T, Wei WN, Wang
YD, He WJ, Wu T, Tan H and Wu TC: Brain-derived neurotrophic factor
promotes growth and migration of multiple myeloma cells. Cancer
Genet Cytogenet. 169:12–20. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ketterer K, Rao S, Friess H, Weiss J,
Büchler MW and Korc M: Reverse transcription-PCR analysis of
laser-captured cells points to potential paracrine and autocrine
actions of neurotrophins in pancreatic cancer. Clin Cancer Res.
9:5127–5136. 2003.PubMed/NCBI
|
|
37
|
Kurokawa T, Katai N, Shibuki H, Kuroiwa S,
Kurimoto Y, Nakayama C and Yoshimura N: BDNF diminishes caspase-2
but not c-Jun immunoreactivity of neurons in retinal ganglion cell
layer after transient ischemia. Invest Ophthalmol Vis Sci.
40:3006–3011. 1999.PubMed/NCBI
|
|
38
|
Perez-Pinera P, Hernandez T, García-Suárez
O, de Carlos F, Germana A, Del Valle M, Astudillo A and Vega JA:
The Trk tyrosine kinase inhibitor K252a regulates growth of lung
adenocarcinomas. Mol Cell Biochem. 295:19–26. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu Z, Ma D, Feng G, Ma Y and Hu H:
Recombinant AAV-mediated expression of human BDNF protects neurons
against cell apoptosis in Abeta-induced neuronal damage model. J
Huazhong Univ Sci Technolog Med Sci. 27:233–236. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Frisch SM and Screaton RA: Anoikis
mechanisms. Curr Opin Cell Biol. 13:555–562. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yu X, Liu L, Cai B, He Y and Wan X:
Suppression of anoikis by the neurotrophic receptor TrkB in human
ovarian cancer. Cancer Sci. 99:543–552. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Koda M, Someya Y, Nishio Y, Kadota R,
Mannoji C, Miyashita T, Okawa A, Murata A and Yamazaki M:
Brain-derived neurotrophic factor suppresses anoikis-induced death
of Schwann cells. Neurosci Lett. 444:143–147. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sinkevicius KW, Kriegel C, Bellaria KJ,
Lee J, Lau AN, Leeman KT, Zhou P, Beede AM, Fillmore CM, Caswell D,
et al: Neurotrophin receptor TrkB promotes lung adenocarcinoma
metastasis. Proc Natl Acad Sci USA. 111:10299–10304. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Daniel PB, Lux W, Samson AL, Schleuning
WD, Niego B, Weiss TW, Tjärnlund-Wolf A and Medcalf RL: Two
conserved regions within the tissue-type plasminogen activator gene
promoter mediate regulation by brain-derived neurotrophic factor.
FEBS J. 274:2411–2423. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hecht M, Schulte JH, Eggert A, Wilting J
and Schweigerer L: The neurotrophin receptor TrkB cooperates with
c-Met in enhancing neuroblastoma invasiveness. Carcinogenesis.
26:2105–2115. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Usui T, Naruo A, Okada M, Hayabe Y and
Yamawaki H: Brain-derived neurotrophic factor promotes angiogenic
tube formation through generation of oxidative stress in human
vascular endothelial cells. Acta Physiol. 211:385–394. 2014.
View Article : Google Scholar
|
|
47
|
Mancino M, Ametller E, Gascón P and
Almendro V: The neuronal influence on tumor progression. Biochim
Biophys Acta. 1816:105–118. 2011.PubMed/NCBI
|
|
48
|
Entschladen F, Palm D, Niggemann B and
Zaenker KS: The cancer's nervous tooth: Considering the neuronal
crosstalk within tumors. Semin Cancer Biol. 18:171–175. 2008.
View Article : Google Scholar : PubMed/NCBI
|
